Novo Nordisk A/S

NONOF·OTC Markets OTCPK·Healthcare
Compare
39.14−0.26 (−0.66%)today
At close: Oct 16, 10:58 AM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close39.40
Open39.14
Day range—
52-week range34.0064.75
Off day high0.00%
Off 52-week high−39.55%
Volume200
Avg. volume (3M)119.67K
Market cap172.73B
EPS (TTM)4.09
Forward P/E—
P/E ratio (TTM)9.57
Dividend yield4.56% (1.80)
Beta (5Y)0.38
Shares outstanding3.34B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin35.35%

Against its peers

Compare in full ›
NONOF NVS LLY AZN PFE BMY
Market cap 172.73B 286.29B 1.12T 256.54B 168.60B 122.05B
P/E (TTM) 9.6 22.8 42.2 23.8 38.9 13.2
Forward P/E — 15.4 26.6 14.6 10.2 9.0
Price/book 5.2 6.9 33.1 5.1 2.0 5.5
Dividend yield 4.56% 3.15% 0.55% 1.94% 5.81% 4.22%
1-year change −28.34% +14.29% +55.39% −1.39% +19.81% +37.07%
Today −0.66% +0.16% +0.43% −0.76% +0.48% −1.35%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Latest news

All NONOF news ›
The Manila Times·Positive

Novo Nordisk A/S - share repurchase programme

Under the programme initiated 6 May 2026, Novo Nordisk will repurchase B shares for an amount up to DKK 11,200,000,010.45 in the period from 6 May 2026 to 1 February 2027. Since the announcement 5 October, the following transactions have…

MarketScreener·

Novo Nordisk A/S : Insider Transactions

Follow insider transactions on Novo Nordisk A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Novo Nordisk A/S Latest insider transactions for Novo Nordisk A/S All…

MarketScreener·Negative

Novo Nordisk A/S : JP Morgan is Neutral

Published on 10/05/2026 at 07:45 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

MarketScreener·Positive

Novo Nordisk A/S: Relative Strength Chart - Stock Nasdaq Copenhagen

Compare Novo Nordisk A/S with the company of your choice via a Relative Strength chart. Real-time NOVO B price, Nasdaq Copenhagen stock exchange Relative Strength Chart Novo Nordisk A/S All financial news and data tailored to specific…

MarketScreener·Negative

Novo Nordisk A/S : Deutsche Bank gives a Sell rating

Published on 10/07/2026 at 03:28 am EDT Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads

MarketScreener·Negative

Novo Nordisk A/S: Official Announcements - Stock Market News

Novo Nordisk and Eli Lilly trade blows September 29, 2026 at 09:34 am EDT Novo Nordisk: Aiming below the mark Novo Sues Rival Lilly Over Weight-Loss Ads GLP-1: The Winners and Losers of Shifting Consumer Habits

From articles in the 4Search news index.

In the news

24mentions in 30 days
24with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.